As of 2024-10-03, the EV/EBITDA ratio of Marinus Pharmaceuticals Inc (MRNS) is -0.65. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNS's latest enterprise value is 85.58 mil USD. MRNS's TTM EBITDA according to its financial statements is -131.46 mil USD. Dividing these 2 quantities gives us the above MRNS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 10.7x | 8.2x |
| Forward P/E multiples | 11.3x - 20.0x | 16.9x |
| Fair Price | (26.92) - (25.39) | (29.87) |
| Upside | -1683.5% - -1593.6% | -1856.9% |
| Date | EV/EBITDA |
| 2024-10-03 | -0.66 |
| 2024-10-02 | -0.65 |
| 2024-10-01 | -0.64 |
| 2024-09-30 | -0.68 |
| 2024-09-27 | -0.71 |
| 2024-09-26 | -0.66 |
| 2024-09-25 | -0.67 |
| 2024-09-24 | -0.73 |
| 2024-09-23 | -0.62 |
| 2024-09-20 | -0.63 |
| 2024-09-19 | -0.61 |
| 2024-09-18 | -0.57 |
| 2024-09-17 | -0.59 |
| 2024-09-16 | -0.59 |
| 2024-09-13 | -0.57 |
| 2024-09-12 | -0.52 |
| 2024-09-11 | -0.52 |
| 2024-09-10 | -0.53 |
| 2024-09-09 | -0.52 |
| 2024-09-06 | -0.53 |
| 2024-09-05 | -0.52 |
| 2024-09-04 | -0.53 |
| 2024-09-03 | -0.54 |
| 2024-08-30 | -0.53 |
| 2024-08-29 | -0.53 |
| 2024-08-28 | -0.52 |
| 2024-08-27 | -0.55 |
| 2024-08-26 | -0.55 |
| 2024-08-23 | -0.48 |
| 2024-08-22 | -0.49 |
| 2024-08-21 | -0.51 |
| 2024-08-20 | -0.50 |
| 2024-08-19 | -0.50 |
| 2024-08-16 | -0.47 |
| 2024-08-15 | -0.45 |
| 2024-08-14 | -0.40 |
| 2024-08-13 | -0.43 |
| 2024-08-12 | -0.45 |
| 2024-08-09 | -0.45 |
| 2024-08-08 | -0.46 |
| 2024-08-07 | -0.42 |
| 2024-08-06 | -0.42 |
| 2024-08-05 | -0.40 |
| 2024-08-02 | -0.48 |
| 2024-08-01 | -0.53 |
| 2024-07-31 | -0.53 |
| 2024-07-30 | -0.52 |
| 2024-07-29 | -0.53 |
| 2024-07-26 | -0.54 |
| 2024-07-25 | -0.53 |